Follow
Danielle Graham
Danielle Graham
Verified email at biogen.com
Title
Cited by
Cited by
Year
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions
V Krishnan, MH Han, DL Graham, O Berton, W Renthal, SJ Russo, ...
Cell 131 (2), 391-404, 2007
25622007
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
O Berton, CA McClung, RJ DiLeone, V Krishnan, W Renthal, SJ Russo, ...
Science 311 (5762), 864-868, 2006
25062006
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ...
New England Journal of Medicine 387 (12), 1099-1110, 2022
5552022
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ...
New England Journal of Medicine 383 (2), 109-119, 2020
5392020
Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse
DL Graham, S Edwards, RK Bachtell, RJ DiLeone, M Rios, DW Self
Nature neuroscience 10 (8), 1029-1037, 2007
4902007
CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits
DL Wallace, MH Han, DL Graham, TA Green, V Vialou, SD Iniguez, ...
Nature neuroscience 12 (2), 200-209, 2009
3792009
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ...
The Lancet Neurology 20 (9), 739-752, 2021
3562021
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
A McCampbell, T Cole, AJ Wegener, GS Tomassy, A Setnicka, BJ Farley, ...
The Journal of clinical investigation 128 (8), 3558-3567, 2018
2832018
Trial of cinpanemab in early Parkinson’s disease
AE Lang, AD Siderowf, EA Macklin, W Poewe, DJ Brooks, HH Fernandez, ...
New England Journal of Medicine 387 (5), 408-420, 2022
2482022
The influence of ΔFosB in the nucleus accumbens on natural reward-related behavior
DL Wallace, V Vialou, L Rios, TL Carle-Florence, S Chakravarty, A Kumar, ...
Journal of Neuroscience 28 (41), 10272-10277, 2008
2322008
Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens
M Barrot, DL Wallace, CA Bolanos, DL Graham, LI Perrotti, RL Neve, ...
Proceedings of the National Academy of Sciences 102 (23), 8357-8362, 2005
1942005
Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens
TA Green, IN Alibhai, CN Roybal, CA Winstanley, DEH Theobald, ...
Biological psychiatry 67 (1), 28-35, 2010
1932010
Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054
M Brys, L Fanning, S Hung, A Ellenbogen, N Penner, M Yang, M Welch, ...
Movement Disorders 34 (8), 1154-1163, 2019
1862019
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
CJ Mummery, A Börjesson-Hanson, DJ Blackburn, EGB Vijverberg, ...
Nature medicine 29 (6), 1437-1447, 2023
1622023
Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression
B Mollenhauer, M Dakna, N Kruse, D Galasko, T Foroud, H Zetterberg, ...
Movement Disorders 35 (11), 1999-2008, 2020
1602020
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
AL Boxer, I Qureshi, M Ahlijanian, M Grundman, LI Golbe, I Litvan, ...
The Lancet Neurology 18 (6), 549-558, 2019
1392019
Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats
EB Larson, DL Graham, RR Arzaga, N Buzin, J Webb, TA Green, CE Bass, ...
Journal of Neuroscience 31 (45), 16447-16457, 2011
1392011
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
DL Graham, AJ Gray, JA Joyce, D Yu, J O'Moore, GA Carlson, ...
Neuropharmacology 79, 307-313, 2014
1382014
Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward
DL Graham, V Krishnan, EB Larson, A Graham, S Edwards, RK Bachtell, ...
Biological psychiatry 65 (8), 696-701, 2009
1372009
Progranulin is a chemoattractant for microglia and stimulates their endocytic activity
F Pickford, J Marcus, LM Camargo, Q Xiao, D Graham, JR Mo, ...
The American journal of pathology 178 (1), 284-295, 2011
1262011
The system can't perform the operation now. Try again later.
Articles 1–20